Clinically actionable hypertrophic cardiomyopathy genes in South Asian Indians
Rao, V. J.; Sairam, T.; Rathinavel, A.; Mohanan, K. S.; Ahamed, H.; Shenthar, J.; Dhandapany, P. S.
Show abstract
BackgroundPrimary hypertrophic cardiomyopathy (HCM) is predominantly a genetic disease causing left ventricular hypertrophy in the absence of other cardiac and systemic metabolic diseases. Currently, limited data exists on the prevalence of clinically actionable gene variants for primary HCM in South Asian Indians (SAI), that is necessary for minimizing disparities in interpreting ancestry-specific variants. ObjectivesThe ClinGen Hereditary Cardiovascular Disorders (HCVD) Gene Curation Expert Panel categorized HCM-causing genes into five categories according to their clinical relevance: definitive, strong, moderate, limited, and disputed. However, comprehensive studies examining this classification in SAI are lacking. MethodsWhole-exome sequencing was performed for 335 primary SAI-HCM patients, including all known cardiovascular genes and clinically actionable gene categories to determine their allele frequencies. ResultsSAI-HCM exomes revealed a total of 194 P/LP and VUS across 26 clinically actionable genes in 119 (35.52%) of the 335 cases. The SAI-HCM cohort exhibited significantly fewer variants in the 12 definitive category genes compared to other global HCM cohorts (17.33% vs. 41.21%, P = 0.0003). For the five strong/moderate genes, no significant difference was observed between the SAI-HCM cohort and other global HCM cohorts (2.59% vs. 2.49%, P = 1). Among the 21 limited and disputed genes, MYH6 showed a significantly higher prevalence of variants in the SAI-HCM cohort than in the other global HCM cohorts (5.07% vs. 1.67%, P = 0.0408). ConclusionsThe clinically actionable gene variants in SAI-HCM cohort differed significantly from other global HCM cohorts, specifically MYBPC3, MYH7, and MYH6.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Variant location is a novel risk factor for individuals with arrhythmogenic cardiomyopathy due to a desmoplakin (DSP) truncating variant 95%
- Prevalence and disease expression of pathogenic and likely pathogenic variants associated with inherited cardiomyopathies in the general population 95%
- Rare Genetic Variants Associated with Sudden Cardiac Arrest in the Young: A Prospective, Population-Based Study 95%
Similar papers in this journal
- Identification and development of Tetra-ARMS PCR-based screening test for a genetic variant of OLA1 (Tyr254Cys) in the human failing heart 94%
- Rare Genomic Copy Number Variants Implicate New Candidate Genes for Bicuspid Aortic Valve 93%
- Mitochondrial dysfunction underlying sporadic inclusion body myositis is ameliorated by the mitochondrial homing drug MA-5 91%
Similar papers in this journal
- Genetic, Clinical, and Sociodemographic Profile in Individuals with Diagnosis or Family History of Hypertrophic Cardiomyopathy: Insights from a Prospective Cohort 95%
- Characterization of the common genetic variation in the Spanish population of Navarre 90%
- Examining the Association between Mitochondrial Genome Variation and Coronary Artery Disease 89%
Similar papers in this journal
- ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel: Reappraisal of Genes associated with Hypertrophic Cardiomyopathy 95%
- Prevalence and clinical importance of titin truncating variants in adults without known congestive heart failure 92%
- Intrahepatic transcriptomics differentiate advanced fibrosis and clinical outcomes in adults with the Fontan circulation 88%
Similar papers in this journal
- Beyond gene-disease validity: capturing structured data on inheritance, allelic-requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions 94%
- A validated heart-specific model for splice-disrupting variants in childhood heart disease 91%
- Genotype–phenotype correlations and novel molecular insights into the DHX30 -associated neurodevelopmental disorders 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.